Martha Morrell, CHIEF MEDICAL OFFICER at NeuroPace Inc (NPCE), sold 26,340 shares at $15.97 ($418K) on 2025-12-15, disclosed to the SEC on 2026-03-04.
Scheduled sale ($418k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.97 | 25,000 | $399K | 95.6% |
| 2 | $13.83 | 1,340 | $19K | 4.4% |
| Total | $15.86 avg | 26,340 | $418K | 100% |
| Filing → |
| NPCE | SELL | 2025-01-28 | $48K | — | Filing → |
| NPCE | SELL | 2024-02-06 | $531K | — | Filing → |
| NPCE | SELL | 2024-02-01 | $379K | — | Filing → |